Asset Details
Do you wish to reserve the book?
sup 18^F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
sup 18^F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors
Do you wish to request the book?
sup 18^F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
sup 18^F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors
2011
Overview
Positron emission tomography (PET) with fluorine-18-fluorodeoxyglucose (^sup 18^F-FDG) has been studied in thymic epithelial tumors. We evaluated the usefulness of ^sup 18^F-FDG PET for monitoring after treatment in unresectable thymic epithelial tumors. Twelve patients with unresectable/metastatic thymic epithelial tumors underwent PET study with ^sup 18^F-FDG before and after chemotherapy or radiotherapy. Response and survival were analyzed according to the ratio of the peak standardized uptake value (SUV) of the tumor to the mean SUV of the mediastinum (T/M ratio). Partial response (PR) evaluated by Response Evaluation Criteria in Solid Tumors (RECIST) was noted in 4 (33%) of 12 patients, and partial metabolic response (PMR) was observed in 6 (50%) of 12 patients. PR was observed in 4 of 6 patients with PMR. In 6 patients with any response, the T/M ratio at post-treatment was significantly lower than at baseline (p = 0.0017). In 6 patients with stable disease (SD), stable metabolic disease (SMD) was observed in 5 by use of ^sup 18^F-FDG PET. No statistically significant difference of ^sup 18^F-FDG uptake between at baseline and post-therapy was observed in 6 patients with SD (p = 0.4157) and SMD (p = 0.8419). Although the overall survival after treatment showed no statistically significant difference between PMR and SMD or progressive metabolic disease in the whole group of patients including thymoma, a statistically significant difference in the overall survival was observed between 5 patients with PMR and 5 patients with non-PMR (p = 0.0280). Our preliminary study suggests that ^sup 18^F-FDG PET is useful for monitoring response and outcome after treatment in unresectable thymic epithelial tumors.[PUBLICATION ABSTRACT]
Publisher
Springer Nature B.V
We currently cannot retrieve any items related to this title. Kindly check back at a later time.